Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
What You Missed On Wall Street On Friday » 16:12
08/12/22
08/12
16:12
08/12/22
16:12
PTR

PetroChina

$44.26 /

-0.65 (-1.45%)

, SNP

Sinopec

$46.38 /

-0.82 (-1.74%)

, ACH

Aluminum Corp. of China

$9.14 /

-0.03 (-0.33%)

, SHI

Sinopec Shanghai

$15.80 /

-0.27 (-1.68%)

, AIV

Aimco

$9.59 /

+0.385 (+4.18%)

, INSE

Inspired Entertainment

$12.67 /

-0.68 (-5.09%)

, AGS

PlayAGS

$7.52 /

+1.525 (+25.46%)

, STLA

Stellantis

$15.42 /

+0.22 (+1.45%)

, DASH

DoorDash

$77.31 /

-0.63 (-0.81%)

, RIVN

Rivian Automotive

$38.88 /

-0.03 (-0.08%)

, ILMN

Illumina

$208.25 /

-19.395 (-8.52%)

, JNJ

Johnson & Johnson

$165.34 /

-1.71 (-1.02%)

, TOST

Toast

$19.61 /

+1.485 (+8.19%)

, LAW

CS Disco

$13.47 /

-15.49 (-53.49%)

, ELF

e.l.f. Beauty

$36.76 /

+0.33 (+0.91%)

, CRM

Salesforce

$189.85 /

+3.09 (+1.65%)

, SNOW

Snowflake

$168.60 /

+0.77 (+0.46%)

, OKTA

Okta

$104.14 /

+1.74 (+1.70%)

, WDAY

Workday

$176.23 /

+10.31 (+6.21%)

, CIEN

Ciena

$54.64 /

+1.74 (+3.29%)

, IIVI

II-VI

$52.83 /

+0.31 (+0.59%)

, SNY

Sanofi

$44.39 /

+0.87 (+2.00%)

, SIX

Six Flags

$24.06 /

+2.94 (+13.92%)

, LXRX

Lexicon

$3.20 /

+0.455 (+16.58%)

, LZ

LegalZoom

$12.97 /

+1.8 (+16.11%)

, PAYO

Payoneer Global

$6.69 /

+1.01 (+17.78%)

, CERT

Certara

$17.65 /

-2.6 (-12.84%)

, SMRT

SmartRent

$3.85 /

-1.71 (-30.76%)

, MKFG

Markforged

$2.90 /

-0.205 (-6.60%)

, OLO

Olo

$8.26 /

-4.765 (-36.60%)

, BR

Broadridge

$183.21 /

+13.54 (+7.98%)

, SPB

Spectrum Brands

$70.08 /

-0.29 (-0.41%)

, HNST

Honest Company

$3.93 /

+0.1 (+2.61%)

, VERO

Venus Concept

/

+

, LFC

China Life Insurance

$7.40 /

-0.11 (-1.47%)

Get caught up quickly on…

ShowHide Related Items >><<
WDAY Workday
$176.23 /

+10.31 (+6.21%)

VERO Venus Concept
/

+

TOST Toast
$19.61 /

+1.485 (+8.19%)

STLA Stellantis
$15.42 /

+0.22 (+1.45%)

SPB Spectrum Brands
$70.08 /

-0.29 (-0.41%)

SNY Sanofi
$44.39 /

+0.87 (+2.00%)

SNP Sinopec
$46.38 /

-0.82 (-1.74%)

SNOW Snowflake
$168.60 /

+0.77 (+0.46%)

SMRT SmartRent
$3.85 /

-1.71 (-30.76%)

SIX Six Flags
$24.06 /

+2.94 (+13.92%)

RIVN Rivian Automotive
$38.88 /

-0.03 (-0.08%)

PTR PetroChina
$44.26 /

-0.65 (-1.45%)

PAYO Payoneer Global
$6.69 /

+1.01 (+17.78%)

OLO Olo
$8.26 /

-4.765 (-36.60%)

OKTA Okta
$104.14 /

+1.74 (+1.70%)

MKFG Markforged
$2.90 /

-0.205 (-6.60%)

LZ LegalZoom
$12.97 /

+1.8 (+16.11%)

LXRX Lexicon
$3.20 /

+0.455 (+16.58%)

LAW CS Disco
$13.47 /

-15.49 (-53.49%)

JNJ Johnson & Johnson
$165.34 /

-1.71 (-1.02%)

INSE Inspired Entertainment
$12.67 /

-0.68 (-5.09%)

ILMN Illumina
$208.25 /

-19.395 (-8.52%)

IIVI II-VI
$52.83 /

+0.31 (+0.59%)

HNST Honest Company
$3.93 /

+0.1 (+2.61%)

ELF e.l.f. Beauty
$36.76 /

+0.33 (+0.91%)

DASH DoorDash
$77.31 /

-0.63 (-0.81%)

CRM Salesforce
$189.85 /

+3.09 (+1.65%)

CIEN Ciena
$54.64 /

+1.74 (+3.29%)

CERT Certara
$17.65 /

-2.6 (-12.84%)

BR Broadridge
$183.21 /

+13.54 (+7.98%)

AIV Aimco
$9.59 /

+0.385 (+4.18%)

AGS PlayAGS
$7.52 /

+1.525 (+25.46%)

ACH Aluminum Corp. of China
$9.14 /

-0.03 (-0.33%)

PTR PetroChina
$44.26 /

-0.65 (-1.45%)

05/23/22 Citi
PetroChina upgraded to Neutral from Sell at Citi
01/04/22 Citi
PetroChina downgraded to Sell from Neutral at Citi
11/29/21 JPMorgan
PetroChina upgraded to Overweight from Underweight at JPMorgan
10/13/21 JPMorgan
PetroChina downgraded to Underweight from Overweight at JPMorgan
SNP Sinopec
$46.38 /

-0.82 (-1.74%)

06/19/22 Goldman Sachs
Sinopec downgraded to Sell from Neutral at Goldman Sachs
05/23/22 Citi
Sinopec downgraded to Sell from Buy at Citi
ACH Aluminum Corp. of China
$9.14 /

-0.03 (-0.33%)

03/23/22 HSBC
Aluminum Corp. of China upgraded to Hold from Reduce at HSBC
01/13/22 Goldman Sachs
Aluminum Corp. of China downgraded to Sell from Buy at Goldman Sachs
SHI Sinopec Shanghai
$15.80 /

-0.27 (-1.68%)

06/28/22 Morgan Stanley
Sinopec Shanghai downgraded to Equal Weight from Overweight at Morgan Stanley
04/19/22 JPMorgan
Sinopec Shanghai downgraded to Underweight from Neutral at JPMorgan
09/27/21 JPMorgan
Sinopec Shanghai initiated with a Neutral at JPMorgan
AIV Aimco
$9.59 /

+0.385 (+4.18%)

INSE Inspired Entertainment
$12.67 /

-0.68 (-5.09%)

07/20/22 Truist
Inspired Entertainment price target lowered to $16 from $18 at Truist
07/14/22 B. Riley
Inspired Entertainment selloff a buying opportunity, says B. Riley
06/28/22 B. Riley
Inspired Entertainment price target lowered to $24 from $30 at B. Riley
06/03/22
Inspired Entertainment management to meet with Truist
AGS PlayAGS
$7.52 /

+1.525 (+25.46%)

08/09/22 B. Riley
PlayAGS price target raised to $14 from $12 at B. Riley
08/01/22 Stifel
PlayAGS price target lowered to $9 from $11 at Stifel
07/20/22 Truist
PlayAGS price target lowered to $12 from $13 at Truist
07/14/22 Deutsche Bank
PlayAGS price target lowered to $11 from $12 at Deutsche Bank
STLA Stellantis
$15.42 /

+0.22 (+1.45%)

08/02/22 RBC Capital
Stellantis price target raised to EUR 21 from EUR 19 at RBC Capital
07/07/22 UBS
Stellantis price target lowered to EUR 18.50 from EUR 25 at UBS
06/28/22 Exane BNP Paribas
Stellantis downgraded to Neutral from Outperform at Exane BNP Paribas
06/16/22 Goldman Sachs
Goldman left Samsara analyst day with stronger conviction
DASH DoorDash
$77.31 /

-0.63 (-0.81%)

08/05/22 Needham
DoorDash price target raised to $115 from $100 at Needham
08/05/22 RBC Capital
DoorDash price target raised to $100 from $94 at RBC Capital
08/05/22 Evercore ISI
DoorDash price target raised to $122 from $98 at Evercore ISI
08/05/22 Barclays
DoorDash price target raised to $90 from $80 at Barclays
RIVN Rivian Automotive
$38.88 /

-0.03 (-0.08%)

08/12/22 DA Davidson
Rivian Automotive price target raised to $27 from $24 at DA Davidson
08/12/22 Morgan Stanley
Rivian Automotive's liqudity can last through most of FY23, says Morgan Stanley
08/12/22 Mizuho
Rivian Automotive price target lowered to $65 from $70 at Mizuho
07/18/22 Deutsche Bank
Rivian Automotive price target lowered to $46 from $69 at Deutsche Bank
ILMN Illumina
$208.25 /

-19.395 (-8.52%)

08/12/22 Morgan Stanley
Illumina price target lowered to $240 from $350 at Morgan Stanley
08/12/22 BofA
Illumina price target lowered to $200 from $220 at BofA
08/12/22 Piper Sandler
Piper a buyer of Illumina weakness ahead of Genomics Forum
08/12/22 Canaccord
Illumina price target lowered to $380 from $450 at Canaccord
JNJ Johnson & Johnson
$165.34 /

-1.71 (-1.02%)

07/21/22 UBS
Johnson & Johnson price target lowered to $180 from $185 at UBS
07/20/22 SVB Securities
Johnson & Johnson price target lowered to $194 from $200 at SVB Securities
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
07/20/22 Citi
Johnson & Johnson price target lowered to $201 from $205 at Citi
TOST Toast
$19.61 /

+1.485 (+8.19%)

08/12/22 Needham
Toast price target raised to $27 from $21 at Needham
08/12/22 KeyBanc
Toast price target raised to $25 from $18 at KeyBanc
05/17/22 Mizuho
Toast price target lowered to $18 from $19 at Mizuho
05/13/22 Needham
Toast price target lowered to $21 from $38 at Needham
LAW CS Disco
$13.47 /

-15.49 (-53.49%)

08/12/22 Canaccord
CS Disco downgraded to Hold at Canaccord as estimates get reset
08/12/22 Stifel
CS Disco price target lowered to $30 from $40 at Stifel
08/12/22 BofA
CS Disco downgraded to Neutral from Buy at BofA
08/12/22 Canaccord
CS Disco downgraded to Hold from Buy at Canaccord
ELF e.l.f. Beauty
$36.76 /

+0.33 (+0.91%)

08/12/22 Cowen
e.l.f. Beauty downgraded to Market Perform at Cowen on valuation
08/12/22 Cowen
e.l.f. Beauty downgraded to Market Perform from Outperform at Cowen
08/04/22 Truist
e.l.f. Beauty price target raised to $40 from $35 at Truist
07/21/22 JPMorgan
e.l.f. Beauty price target raised to $35 from $30 at JPMorgan
CRM Salesforce
$189.85 /

+3.09 (+1.65%)

08/11/22 Guggenheim
Salesforce initiated with a Sell at Guggenheim
08/09/22 UBS
UBS sees 'downtick' in partner tone ahead of Salesforce earnings
07/18/22 Piper Sandler
Salesforce price target lowered to $220 from $250 at Piper Sandler
06/02/22 Loop Capital
Salesforce price target lowered to $175 from $225 at Loop Capital
SNOW Snowflake
$168.60 /

+0.77 (+0.46%)

08/11/22 Guggenheim
Snowflake initiated with a Sell at Guggenheim
08/02/22 BTIG
Snowflake downgraded to Neutral from Buy at BTIG
07/18/22 Piper Sandler
Snowflake price target lowered to $164 from $165 at Piper Sandler
07/12/22 Baird
Baird starts 'revolutionary' Snowflake with Outperform, $200 target
OKTA Okta
$104.14 /

+1.74 (+1.70%)

08/11/22 Guggenheim
Okta initiated with a Sell at Guggenheim
08/10/22 DA Davidson
Okta cut to Neutral at DA Davidson on higher sales turnover and competition
08/10/22 DA Davidson
Okta downgraded to Neutral from Buy at DA Davidson
08/03/22 Stifel
Ping Identity downgraded to Hold from Buy at Stifel
WDAY Workday
$176.23 /

+10.31 (+6.21%)

08/11/22 Guggenheim
Workday initiated with a Sell at Guggenheim
07/18/22 Piper Sandler
Workday price target lowered to $175 from $230 at Piper Sandler
05/27/22 DA Davidson
Workday price target lowered to $220 from $250 at DA Davidson
CIEN Ciena
$54.64 /

+1.74 (+3.29%)

08/12/22 Morgan Stanley
Ciena upgraded to Overweight at Morgan Stanley as supply chain improves
08/12/22 Morgan Stanley
Ciena upgraded to Overweight from Equal Weight at Morgan Stanley
08/04/22 MKM Partners
Ciena assumed with a Buy at MKM Partners
07/14/22 JPMorgan
Ciena price target lowered to $62 from $72 at JPMorgan
IIVI II-VI
$52.83 /

+0.31 (+0.59%)

08/12/22 Morgan Stanley
II-VI downgraded to Equal Weight from Overweight at Morgan Stanley
07/25/22 Barclays
II-VI price target lowered to $47 from $65 at Barclays
07/01/22 Craig-Hallum
II-VI price target lowered to $80 from $85 at Craig-Hallum
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
SNY Sanofi
$44.39 /

+0.87 (+2.00%)

08/12/22 Deutsche Bank
Deutsche Bank raises Sanofi to Hold, calls Zantac 'knee-jerk' reaction overdone
08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
08/12/22 Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
SIX Six Flags
$24.06 /

+2.94 (+13.92%)

08/12/22 Deutsche Bank
Six Flags price target lowered to $38 from $56 at Deutsche Bank
08/12/22 Truist
Six Flags price target lowered to $20 from $32 at Truist
08/12/22 Stifel
Six Flags price target lowered to $28 from $35 at Stifel
08/12/22 KeyBanc
Six Flags downgraded to Sector Weight at KeyBanc after 'indefensible' Q2
LXRX Lexicon
$3.20 /

+0.455 (+16.58%)

08/12/22 Piper Sandler
Lexicon initiated with an Overweight at Piper Sandler
07/01/22 Citi
Citi disagrees with Lexicon selloff yesterday, ups target to $20
03/01/22 Citi
Lexicon selloff on filing delay a buying opportunity, says Citi
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
LZ LegalZoom
$12.97 /

+1.8 (+16.11%)

08/12/22 Credit Suisse
LegalZoom price target lowered to $19 from $24 at Credit Suisse
07/28/22 Morgan Stanley
LegalZoom downgraded to Underweight on estimate risk at Morgan Stanley
07/28/22 Morgan Stanley
LegalZoom downgraded to Underweight from Equal Weight at Morgan Stanley
07/14/22 Morgan Stanley
LegalZoom price target lowered to $12 from $13 at Morgan Stanley
PAYO Payoneer Global
$6.69 /

+1.01 (+17.78%)

07/14/22 Goldman Sachs
Payoneer Global upgraded to Buy from Neutral at Goldman Sachs
05/13/22 Northland
Payoneer Global price target lowered to $9 from $14 at Northland
05/13/22 Citi
Payoneer Global price target raised to $7.50 from $6.50 at Citi
03/04/22 Needham
Payoneer Global price target lowered to $7 from $13 at Needham
CERT Certara
$17.65 /

-2.6 (-12.84%)

08/10/22 Piper Sandler
Certara price target lowered to $25 from $28 at Piper Sandler
07/15/22 SVB Securities
Certara initiated with an Outperform at SVB Securities (earlier)
07/13/22 Barclays
Certara price target lowered to $24 from $25 at Barclays
07/01/22 Piper Sandler
Certara initiated with an Overweight at Piper Sandler
SMRT SmartRent
$3.85 /

-1.71 (-30.76%)

08/12/22 Cantor Fitzgerald
SmartRent price target lowered to $5.25 from $6.00 at Cantor Fitzgerald
07/22/22 Cantor Fitzgerald
SmartRent assumed with an Overweight at Cantor Fitzgerald
07/19/22 Keefe Bruyette
Bain Capital sold 5% of stake in SmartRent, says Keefe Bruyette
05/25/22 Compass Point
Compass Point starts SmartRent at Buy, sees 'exponential growth potential'
MKFG Markforged
$2.90 /

-0.205 (-6.60%)

06/10/22 Berenberg
Markforged initiated with a Buy at Berenberg
05/13/22 Citi
Markforged price target lowered to $3 from $5 at Citi
12/21/21 Goldman Sachs
Markforged initiated with a Buy at Goldman Sachs
12/14/21 Craig-Hallum
Craig-Hallum bullish on Markforged, initiates with a Buy
OLO Olo
$8.26 /

-4.765 (-36.60%)

08/12/22 RBC Capital
Olo price target lowered to $12 from $17 at RBC Capital
08/12/22 Truist
Olo price target lowered to $16 from $25 at Truist
08/12/22 Piper Sandler
Olo downgraded to Neutral from Overweight at Piper Sandler
08/12/22 Stifel
Olo downgraded to Hold from Buy at Stifel
BR Broadridge
$183.21 /

+13.54 (+7.98%)

08/17/21 JPMorgan
Broadridge price target raised to $197 from $181 at JPMorgan
08/16/21 DA Davidson
Broadridge price target raised to $158 from $152 at DA Davidson
08/13/21 JPMorgan
Broadridge assumed with an Overweight at JPMorgan
SPB Spectrum Brands
$70.08 /

-0.29 (-0.41%)

07/18/22 Oppenheimer
Spectrum Brands price target lowered to $95 from $125 at Oppenheimer
07/18/22 UBS
Spectrum Brands price target lowered to $109 from $119 at UBS
07/18/22 Wells Fargo
Spectrum Brands price target lowered to $100 from $122 at Wells Fargo
07/13/22 Raymond James
Spectrum Brands initiated with a Market Perform at Raymond James
HNST Honest Company
$3.93 /

+0.1 (+2.61%)

06/09/22 Loop Capital
Loop Capital cuts Honest Company to Hold amid pressure reported in mass retail
06/09/22 Loop Capital
Honest Company downgraded to Hold from Buy at Loop Capital
05/16/22 Loop Capital
Honest Company price target lowered to $5 from $8 at Loop Capital
03/28/22 Citi
Honest Company shares look 'awfully cheap' after selloff, says Citi
VERO Venus Concept
/

+

06/24/22 BTIG
Venus Concept price target lowered to $5.50 from $7.00 at BTIG
11/12/21 Stifel
Venus Concept price target trimmed to $2 at Stifel after Q3 miss
LFC China Life Insurance
$7.40 /

-0.11 (-1.47%)

08/05/22 JPMorgan
China Life Insurance upgraded to Overweight from Neutral at JPMorgan
WDAY Workday
$176.23 /

+10.31 (+6.21%)

VERO Venus Concept
/

+

TOST Toast
$19.61 /

+1.485 (+8.19%)

STLA Stellantis
$15.42 /

+0.22 (+1.45%)

SPB Spectrum Brands
$70.08 /

-0.29 (-0.41%)

SNY Sanofi
$44.39 /

+0.87 (+2.00%)

SNOW Snowflake
$168.60 /

+0.77 (+0.46%)

SMRT SmartRent
$3.85 /

-1.71 (-30.76%)

SIX Six Flags
$24.06 /

+2.94 (+13.92%)

RIVN Rivian Automotive
$38.88 /

-0.03 (-0.08%)

PTR PetroChina
$44.26 /

-0.65 (-1.45%)

PAYO Payoneer Global
$6.69 /

+1.01 (+17.78%)

OLO Olo
$8.26 /

-4.765 (-36.60%)

OKTA Okta
$104.14 /

+1.74 (+1.70%)

MKFG Markforged
$2.90 /

-0.205 (-6.60%)

LZ LegalZoom
$12.97 /

+1.8 (+16.11%)

LXRX Lexicon
$3.20 /

+0.455 (+16.58%)

LAW CS Disco
$13.47 /

-15.49 (-53.49%)

JNJ Johnson & Johnson
$165.34 /

-1.71 (-1.02%)

INSE Inspired Entertainment
$12.67 /

-0.68 (-5.09%)

ILMN Illumina
$208.25 /

-19.395 (-8.52%)

IIVI II-VI
$52.83 /

+0.31 (+0.59%)

HNST Honest Company
$3.93 /

+0.1 (+2.61%)

ELF e.l.f. Beauty
$36.76 /

+0.33 (+0.91%)

DASH DoorDash
$77.31 /

-0.63 (-0.81%)

CRM Salesforce
$189.85 /

+3.09 (+1.65%)

CIEN Ciena
$54.64 /

+1.74 (+3.29%)

CERT Certara
$17.65 /

-2.6 (-12.84%)

BR Broadridge
$183.21 /

+13.54 (+7.98%)

AGS PlayAGS
$7.52 /

+1.525 (+25.46%)

  • 12
    Aug
  • 18
    Nov
  • 10
    Nov
  • 22
    Sep
  • 15
    Sep
  • 09
    Sep
  • 19
    Aug
STLA Stellantis
$15.42 /

+0.22 (+1.45%)

SNY Sanofi
$44.39 /

+0.87 (+2.00%)

SNOW Snowflake
$168.60 /

+0.77 (+0.46%)

RIVN Rivian Automotive
$38.88 /

-0.03 (-0.08%)

PTR PetroChina
$44.26 /

-0.65 (-1.45%)

OKTA Okta
$104.14 /

+1.74 (+1.70%)

JNJ Johnson & Johnson
$165.34 /

-1.71 (-1.02%)

INSE Inspired Entertainment
$12.67 /

-0.68 (-5.09%)

ILMN Illumina
$208.25 /

-19.395 (-8.52%)

IIVI II-VI
$52.83 /

+0.31 (+0.59%)

DASH DoorDash
$77.31 /

-0.63 (-0.81%)

CRM Salesforce
$189.85 /

+3.09 (+1.65%)

AIV Aimco
$9.59 /

+0.385 (+4.18%)

WDAY Workday
$176.23 /

+10.31 (+6.21%)

TOST Toast
$19.61 /

+1.485 (+8.19%)

STLA Stellantis
$15.42 /

+0.22 (+1.45%)

SNY Sanofi
$44.39 /

+0.87 (+2.00%)

SNOW Snowflake
$168.60 /

+0.77 (+0.46%)

SMRT SmartRent
$3.85 /

-1.71 (-30.76%)

SIX Six Flags
$24.06 /

+2.94 (+13.92%)

RIVN Rivian Automotive
$38.88 /

-0.03 (-0.08%)

PTR PetroChina
$44.26 /

-0.65 (-1.45%)

OKTA Okta
$104.14 /

+1.74 (+1.70%)

LZ LegalZoom
$12.97 /

+1.8 (+16.11%)

LAW CS Disco
$13.47 /

-15.49 (-53.49%)

JNJ Johnson & Johnson
$165.34 /

-1.71 (-1.02%)

INSE Inspired Entertainment
$12.67 /

-0.68 (-5.09%)

ILMN Illumina
$208.25 /

-19.395 (-8.52%)

IIVI II-VI
$52.83 /

+0.31 (+0.59%)

HNST Honest Company
$3.93 /

+0.1 (+2.61%)

ELF e.l.f. Beauty
$36.76 /

+0.33 (+0.91%)

DASH DoorDash
$77.31 /

-0.63 (-0.81%)

CRM Salesforce
$189.85 /

+3.09 (+1.65%)

CIEN Ciena
$54.64 /

+1.74 (+3.29%)

WDAY Workday
$176.23 /

+10.31 (+6.21%)

TOST Toast
$19.61 /

+1.485 (+8.19%)

STLA Stellantis
$15.42 /

+0.22 (+1.45%)

SNOW Snowflake
$168.60 /

+0.77 (+0.46%)

RIVN Rivian Automotive
$38.88 /

-0.03 (-0.08%)

PAYO Payoneer Global
$6.69 /

+1.01 (+17.78%)

OKTA Okta
$104.14 /

+1.74 (+1.70%)

JNJ Johnson & Johnson
$165.34 /

-1.71 (-1.02%)

ILMN Illumina
$208.25 /

-19.395 (-8.52%)

HNST Honest Company
$3.93 /

+0.1 (+2.61%)

DASH DoorDash
$77.31 /

-0.63 (-0.81%)

CRM Salesforce
$189.85 /

+3.09 (+1.65%)

BR Broadridge
$183.21 /

+13.54 (+7.98%)

On The Fly
What You Missed On Wall Street This Morning » 12:11
08/12/22
08/12
12:11
08/12/22
12:11
RIVN

Rivian Automotive

$38.87 /

-0.04 (-0.10%)

, ILMN

Illumina

$208.12 /

-19.52 (-8.57%)

, JNJ

Johnson & Johnson

$166.17 /

-0.88 (-0.53%)

, TOST

Toast

$20.39 /

+2.265 (+12.50%)

, LAW

CS Disco

$13.62 /

-15.345 (-52.99%)

, LFC

China Life Insurance

$7.30 /

-0.21 (-2.80%)

, PTR

PetroChina

$43.46 /

-1.45 (-3.23%)

, SNP

Sinopec

$45.50 /

-1.705 (-3.61%)

, ACH

Aluminum Corp. of China

$8.93 /

-0.24 (-2.62%)

, SHI

Sinopec Shanghai

$15.54 /

-0.53 (-3.30%)

, LNG

Cheniere Energy

$156.49 /

+1.82 (+1.18%)

, AIV

Aimco

$9.63 /

+0.425 (+4.62%)

, HSBC

HSBC

$33.40 /

-0.1 (-0.30%)

, NVS

Novartis

$85.51 /

+0.065 (+0.08%)

, LXRX

Lexicon

$3.14 /

+0.395 (+14.39%)

, GWH

ESS Inc.

$4.93 /

+0.745 (+17.80%)

, LZ

LegalZoom

$13.24 /

+2.07 (+18.53%)

, PAYO

Payoneer Global

$7.09 /

+1.405 (+24.74%)

, CERT

Certara

$17.27 /

-2.98 (-14.72%)

, SMRT

SmartRent

$3.78 /

-1.785 (-32.10%)

, MKFG

Markforged

$2.74 /

-0.365 (-11.76%)

, OLO

Olo

$8.74 /

-4.28 (-32.87%)

, BR

Broadridge

$178.16 /

+8.485 (+5.00%)

, SPB

Spectrum Brands

$69.09 /

-1.28 (-1.82%)

, HNST

Honest Company

$3.87 /

+0.035 (+0.91%)

, VERO

Venus Concept

/

+

, ELF

e.l.f. Beauty

$36.28 /

-0.15 (-0.41%)

, SNOW

Snowflake

$166.28 /

-1.55 (-0.92%)

, CRM

Salesforce

$187.47 /

+0.71 (+0.38%)

, OKTA

Okta

$102.51 /

+0.11 (+0.11%)

, WDAY

Workday

$174.90 /

+8.98 (+5.41%)

, CIEN

Ciena

$54.30 /

+1.4 (+2.65%)

, IIVI

II-VI

$52.77 /

+0.25 (+0.48%)

, SNY

Sanofi

$44.19 /

+0.67 (+1.54%)

, SIX

Six Flags

$23.19 /

+2.07 (+9.80%)

Get caught up quickly on…

ShowHide Related Items >><<
WDAY Workday
$174.90 /

+8.98 (+5.41%)

VERO Venus Concept
/

+

TOST Toast
$20.39 /

+2.265 (+12.50%)

SPB Spectrum Brands
$69.09 /

-1.28 (-1.82%)

SNY Sanofi
$44.19 /

+0.67 (+1.54%)

SNP Sinopec
$45.50 /

-1.705 (-3.61%)

SNOW Snowflake
$166.28 /

-1.55 (-0.92%)

SMRT SmartRent
$3.78 /

-1.785 (-32.10%)

SIX Six Flags
$23.19 /

+2.07 (+9.80%)

RIVN Rivian Automotive
$38.87 /

-0.04 (-0.10%)

PTR PetroChina
$43.46 /

-1.45 (-3.23%)

PAYO Payoneer Global
$7.09 /

+1.405 (+24.74%)

OLO Olo
$8.74 /

-4.28 (-32.87%)

OKTA Okta
$102.51 /

+0.11 (+0.11%)

NVS Novartis
$85.51 /

+0.065 (+0.08%)

MKFG Markforged
$2.74 /

-0.365 (-11.76%)

LZ LegalZoom
$13.24 /

+2.07 (+18.53%)

LXRX Lexicon
$3.14 /

+0.395 (+14.39%)

LNG Cheniere Energy
$156.49 /

+1.82 (+1.18%)

LAW CS Disco
$13.62 /

-15.345 (-52.99%)

JNJ Johnson & Johnson
$166.17 /

-0.88 (-0.53%)

ILMN Illumina
$208.12 /

-19.52 (-8.57%)

IIVI II-VI
$52.77 /

+0.25 (+0.48%)

HSBC HSBC
$33.40 /

-0.1 (-0.30%)

HNST Honest Company
$3.87 /

+0.035 (+0.91%)

GWH ESS Inc.
$4.93 /

+0.745 (+17.80%)

ELF e.l.f. Beauty
$36.28 /

-0.15 (-0.41%)

CRM Salesforce
$187.47 /

+0.71 (+0.38%)

CIEN Ciena
$54.30 /

+1.4 (+2.65%)

CERT Certara
$17.27 /

-2.98 (-14.72%)

BR Broadridge
$178.16 /

+8.485 (+5.00%)

AIV Aimco
$9.63 /

+0.425 (+4.62%)

ACH Aluminum Corp. of China
$8.93 /

-0.24 (-2.62%)

RIVN Rivian Automotive
$38.87 /

-0.04 (-0.10%)

08/12/22 DA Davidson
Rivian Automotive price target raised to $27 from $24 at DA Davidson
08/12/22 Morgan Stanley
Rivian Automotive's liqudity can last through most of FY23, says Morgan Stanley
08/12/22 Mizuho
Rivian Automotive price target lowered to $65 from $70 at Mizuho
07/18/22 Deutsche Bank
Rivian Automotive price target lowered to $46 from $69 at Deutsche Bank
ILMN Illumina
$208.12 /

-19.52 (-8.57%)

08/12/22 Morgan Stanley
Illumina price target lowered to $240 from $350 at Morgan Stanley
08/12/22 BofA
Illumina price target lowered to $200 from $220 at BofA
08/12/22 Piper Sandler
Piper a buyer of Illumina weakness ahead of Genomics Forum
08/12/22 Canaccord
Illumina price target lowered to $380 from $450 at Canaccord
JNJ Johnson & Johnson
$166.17 /

-0.88 (-0.53%)

07/21/22 UBS
Johnson & Johnson price target lowered to $180 from $185 at UBS
07/20/22 SVB Securities
Johnson & Johnson price target lowered to $194 from $200 at SVB Securities
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
07/20/22 Citi
Johnson & Johnson price target lowered to $201 from $205 at Citi
TOST Toast
$20.39 /

+2.265 (+12.50%)

08/12/22 Needham
Toast price target raised to $27 from $21 at Needham
08/12/22 KeyBanc
Toast price target raised to $25 from $18 at KeyBanc
05/17/22 Mizuho
Toast price target lowered to $18 from $19 at Mizuho
05/13/22 Needham
Toast price target lowered to $21 from $38 at Needham
LAW CS Disco
$13.62 /

-15.345 (-52.99%)

08/12/22 Canaccord
CS Disco downgraded to Hold at Canaccord as estimates get reset
08/12/22 Stifel
CS Disco price target lowered to $30 from $40 at Stifel
08/12/22 BofA
CS Disco downgraded to Neutral from Buy at BofA
08/12/22 Canaccord
CS Disco downgraded to Hold from Buy at Canaccord
LFC China Life Insurance
$7.30 /

-0.21 (-2.80%)

08/05/22 JPMorgan
China Life Insurance upgraded to Overweight from Neutral at JPMorgan
PTR PetroChina
$43.46 /

-1.45 (-3.23%)

05/23/22 Citi
PetroChina upgraded to Neutral from Sell at Citi
01/04/22 Citi
PetroChina downgraded to Sell from Neutral at Citi
11/29/21 JPMorgan
PetroChina upgraded to Overweight from Underweight at JPMorgan
10/13/21 JPMorgan
PetroChina downgraded to Underweight from Overweight at JPMorgan
SNP Sinopec
$45.50 /

-1.705 (-3.61%)

06/19/22 Goldman Sachs
Sinopec downgraded to Sell from Neutral at Goldman Sachs
05/23/22 Citi
Sinopec downgraded to Sell from Buy at Citi
ACH Aluminum Corp. of China
$8.93 /

-0.24 (-2.62%)

03/23/22 HSBC
Aluminum Corp. of China upgraded to Hold from Reduce at HSBC
01/13/22 Goldman Sachs
Aluminum Corp. of China downgraded to Sell from Buy at Goldman Sachs
SHI Sinopec Shanghai
$15.54 /

-0.53 (-3.30%)

06/28/22 Morgan Stanley
Sinopec Shanghai downgraded to Equal Weight from Overweight at Morgan Stanley
04/19/22 JPMorgan
Sinopec Shanghai downgraded to Underweight from Neutral at JPMorgan
09/27/21 JPMorgan
Sinopec Shanghai initiated with a Neutral at JPMorgan
LNG Cheniere Energy
$156.49 /

+1.82 (+1.18%)

08/05/22 Mizuho
Cheniere Energy price target raised to $167 from $159 at Mizuho
05/31/22 Wells Fargo
Wells Fargo downgrades Cheniere Energy Partners to Underweight on valuation
05/23/22 RBC Capital
Cheniere Energy price target raised to $178 from $151 at RBC Capital
05/12/22 JPMorgan
Cheniere Energy price target raised to $192 from $183 at JPMorgan
AIV Aimco
$9.63 /

+0.425 (+4.62%)

HSBC HSBC
$33.40 /

-0.1 (-0.30%)

08/08/22 RBC Capital
HSBC price target raised to 650 GBp from 590 GBp at RBC Capital
08/03/22 Goldman Sachs
HSBC downgraded to Neutral from Buy at Goldman Sachs
08/03/22 Berenberg
HSBC price target raised to 625 GBp from 560 GBp at Berenberg
08/03/22 UBS
HSBC price target raised to 680 GBp from 635 GBp at UBS
NVS Novartis
$85.51 /

+0.065 (+0.08%)

08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
08/04/22 Truist
Truist sees Novartis, Vertex as logical suitors for Global Blood
07/20/22 JPMorgan
Novartis price target raised to CHF 81 from CHF 80 at JPMorgan
07/20/22 Piper Sandler
Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
LXRX Lexicon
$3.14 /

+0.395 (+14.39%)

08/12/22 Piper Sandler
Lexicon initiated with an Overweight at Piper Sandler
07/01/22 Citi
Citi disagrees with Lexicon selloff yesterday, ups target to $20
03/01/22 Citi
Lexicon selloff on filing delay a buying opportunity, says Citi
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
GWH ESS Inc.
$4.93 /

+0.745 (+17.80%)

07/13/22 Canaccord
ESS Inc. assumed with a Hold at Canaccord
06/29/22 Chardan
ESS Inc. initiated with a Neutral at Chardan
03/30/22 Deutsche Bank
ESS Inc. initiated with a Hold at Deutsche Bank
03/22/22 Guggenheim
Guggenheim starts ESS Inc. at Buy on flow battery odds of success
LZ LegalZoom
$13.24 /

+2.07 (+18.53%)

08/12/22 Credit Suisse
LegalZoom price target lowered to $19 from $24 at Credit Suisse
07/28/22 Morgan Stanley
LegalZoom downgraded to Underweight on estimate risk at Morgan Stanley
07/28/22 Morgan Stanley
LegalZoom downgraded to Underweight from Equal Weight at Morgan Stanley
07/14/22 Morgan Stanley
LegalZoom price target lowered to $12 from $13 at Morgan Stanley
PAYO Payoneer Global
$7.09 /

+1.405 (+24.74%)

07/14/22 Goldman Sachs
Payoneer Global upgraded to Buy from Neutral at Goldman Sachs
05/13/22 Northland
Payoneer Global price target lowered to $9 from $14 at Northland
05/13/22 Citi
Payoneer Global price target raised to $7.50 from $6.50 at Citi
03/04/22 Needham
Payoneer Global price target lowered to $7 from $13 at Needham
CERT Certara
$17.27 /

-2.98 (-14.72%)

08/10/22 Piper Sandler
Certara price target lowered to $25 from $28 at Piper Sandler
07/15/22 SVB Securities
Certara initiated with an Outperform at SVB Securities (earlier)
07/13/22 Barclays
Certara price target lowered to $24 from $25 at Barclays
07/01/22 Piper Sandler
Certara initiated with an Overweight at Piper Sandler
SMRT SmartRent
$3.78 /

-1.785 (-32.10%)

08/12/22 Cantor Fitzgerald
SmartRent price target lowered to $5.25 from $6.00 at Cantor Fitzgerald
07/22/22 Cantor Fitzgerald
SmartRent assumed with an Overweight at Cantor Fitzgerald
07/19/22 Keefe Bruyette
Bain Capital sold 5% of stake in SmartRent, says Keefe Bruyette
05/25/22 Compass Point
Compass Point starts SmartRent at Buy, sees 'exponential growth potential'
MKFG Markforged
$2.74 /

-0.365 (-11.76%)

06/10/22 Berenberg
Markforged initiated with a Buy at Berenberg
05/13/22 Citi
Markforged price target lowered to $3 from $5 at Citi
12/21/21 Goldman Sachs
Markforged initiated with a Buy at Goldman Sachs
12/14/21 Craig-Hallum
Craig-Hallum bullish on Markforged, initiates with a Buy
OLO Olo
$8.74 /

-4.28 (-32.87%)

08/12/22 RBC Capital
Olo price target lowered to $12 from $17 at RBC Capital
08/12/22 Truist
Olo price target lowered to $16 from $25 at Truist
08/12/22 Piper Sandler
Olo downgraded to Neutral from Overweight at Piper Sandler
08/12/22 Stifel
Olo downgraded to Hold from Buy at Stifel
BR Broadridge
$178.16 /

+8.485 (+5.00%)

08/17/21 JPMorgan
Broadridge price target raised to $197 from $181 at JPMorgan
08/16/21 DA Davidson
Broadridge price target raised to $158 from $152 at DA Davidson
08/13/21 JPMorgan
Broadridge assumed with an Overweight at JPMorgan
SPB Spectrum Brands
$69.09 /

-1.28 (-1.82%)

07/18/22 Oppenheimer
Spectrum Brands price target lowered to $95 from $125 at Oppenheimer
07/18/22 UBS
Spectrum Brands price target lowered to $109 from $119 at UBS
07/18/22 Wells Fargo
Spectrum Brands price target lowered to $100 from $122 at Wells Fargo
07/13/22 Raymond James
Spectrum Brands initiated with a Market Perform at Raymond James
HNST Honest Company
$3.87 /

+0.035 (+0.91%)

06/09/22 Loop Capital
Loop Capital cuts Honest Company to Hold amid pressure reported in mass retail
06/09/22 Loop Capital
Honest Company downgraded to Hold from Buy at Loop Capital
05/16/22 Loop Capital
Honest Company price target lowered to $5 from $8 at Loop Capital
03/28/22 Citi
Honest Company shares look 'awfully cheap' after selloff, says Citi
VERO Venus Concept
/

+

06/24/22 BTIG
Venus Concept price target lowered to $5.50 from $7.00 at BTIG
11/12/21 Stifel
Venus Concept price target trimmed to $2 at Stifel after Q3 miss
ELF e.l.f. Beauty
$36.28 /

-0.15 (-0.41%)

08/12/22 Cowen
e.l.f. Beauty downgraded to Market Perform at Cowen on valuation
08/12/22 Cowen
e.l.f. Beauty downgraded to Market Perform from Outperform at Cowen
08/04/22 Truist
e.l.f. Beauty price target raised to $40 from $35 at Truist
07/21/22 JPMorgan
e.l.f. Beauty price target raised to $35 from $30 at JPMorgan
SNOW Snowflake
$166.28 /

-1.55 (-0.92%)

08/11/22 Guggenheim
Snowflake initiated with a Sell at Guggenheim
08/02/22 BTIG
Snowflake downgraded to Neutral from Buy at BTIG
07/18/22 Piper Sandler
Snowflake price target lowered to $164 from $165 at Piper Sandler
07/12/22 Baird
Baird starts 'revolutionary' Snowflake with Outperform, $200 target
CRM Salesforce
$187.47 /

+0.71 (+0.38%)

08/11/22 Guggenheim
Salesforce initiated with a Sell at Guggenheim
08/09/22 UBS
UBS sees 'downtick' in partner tone ahead of Salesforce earnings
07/18/22 Piper Sandler
Salesforce price target lowered to $220 from $250 at Piper Sandler
06/02/22 Loop Capital
Salesforce price target lowered to $175 from $225 at Loop Capital
OKTA Okta
$102.51 /

+0.11 (+0.11%)

08/11/22 Guggenheim
Okta initiated with a Sell at Guggenheim
08/10/22 DA Davidson
Okta cut to Neutral at DA Davidson on higher sales turnover and competition
08/10/22 DA Davidson
Okta downgraded to Neutral from Buy at DA Davidson
08/03/22 Stifel
Ping Identity downgraded to Hold from Buy at Stifel
WDAY Workday
$174.90 /

+8.98 (+5.41%)

08/11/22 Guggenheim
Workday initiated with a Sell at Guggenheim
07/18/22 Piper Sandler
Workday price target lowered to $175 from $230 at Piper Sandler
05/27/22 DA Davidson
Workday price target lowered to $220 from $250 at DA Davidson
CIEN Ciena
$54.30 /

+1.4 (+2.65%)

08/12/22 Morgan Stanley
Ciena upgraded to Overweight at Morgan Stanley as supply chain improves
08/12/22 Morgan Stanley
Ciena upgraded to Overweight from Equal Weight at Morgan Stanley
08/04/22 MKM Partners
Ciena assumed with a Buy at MKM Partners
07/14/22 JPMorgan
Ciena price target lowered to $62 from $72 at JPMorgan
IIVI II-VI
$52.77 /

+0.25 (+0.48%)

08/12/22 Morgan Stanley
II-VI downgraded to Equal Weight from Overweight at Morgan Stanley
07/25/22 Barclays
II-VI price target lowered to $47 from $65 at Barclays
07/01/22 Craig-Hallum
II-VI price target lowered to $80 from $85 at Craig-Hallum
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
SNY Sanofi
$44.19 /

+0.67 (+1.54%)

08/12/22 Deutsche Bank
Deutsche Bank raises Sanofi to Hold, calls Zantac 'knee-jerk' reaction overdone
08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
08/12/22 Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
SIX Six Flags
$23.19 /

+2.07 (+9.80%)

08/12/22 Deutsche Bank
Six Flags price target lowered to $38 from $56 at Deutsche Bank
08/12/22 Truist
Six Flags price target lowered to $20 from $32 at Truist
08/12/22 Stifel
Six Flags price target lowered to $28 from $35 at Stifel
08/12/22 KeyBanc
Six Flags downgraded to Sector Weight at KeyBanc after 'indefensible' Q2
WDAY Workday
$174.90 /

+8.98 (+5.41%)

VERO Venus Concept
/

+

TOST Toast
$20.39 /

+2.265 (+12.50%)

SPB Spectrum Brands
$69.09 /

-1.28 (-1.82%)

SNY Sanofi
$44.19 /

+0.67 (+1.54%)

SNOW Snowflake
$166.28 /

-1.55 (-0.92%)

SMRT SmartRent
$3.78 /

-1.785 (-32.10%)

SIX Six Flags
$23.19 /

+2.07 (+9.80%)

RIVN Rivian Automotive
$38.87 /

-0.04 (-0.10%)

PTR PetroChina
$43.46 /

-1.45 (-3.23%)

PAYO Payoneer Global
$7.09 /

+1.405 (+24.74%)

OLO Olo
$8.74 /

-4.28 (-32.87%)

OKTA Okta
$102.51 /

+0.11 (+0.11%)

NVS Novartis
$85.51 /

+0.065 (+0.08%)

MKFG Markforged
$2.74 /

-0.365 (-11.76%)

LZ LegalZoom
$13.24 /

+2.07 (+18.53%)

LXRX Lexicon
$3.14 /

+0.395 (+14.39%)

LNG Cheniere Energy
$156.49 /

+1.82 (+1.18%)

LAW CS Disco
$13.62 /

-15.345 (-52.99%)

JNJ Johnson & Johnson
$166.17 /

-0.88 (-0.53%)

ILMN Illumina
$208.12 /

-19.52 (-8.57%)

IIVI II-VI
$52.77 /

+0.25 (+0.48%)

HSBC HSBC
$33.40 /

-0.1 (-0.30%)

HNST Honest Company
$3.87 /

+0.035 (+0.91%)

GWH ESS Inc.
$4.93 /

+0.745 (+17.80%)

ELF e.l.f. Beauty
$36.28 /

-0.15 (-0.41%)

CRM Salesforce
$187.47 /

+0.71 (+0.38%)

CIEN Ciena
$54.30 /

+1.4 (+2.65%)

CERT Certara
$17.27 /

-2.98 (-14.72%)

BR Broadridge
$178.16 /

+8.485 (+5.00%)

  • 12
    Aug
  • 18
    Nov
  • 10
    Nov
  • 22
    Sep
  • 15
    Sep
  • 09
    Sep
SNY Sanofi
$44.19 /

+0.67 (+1.54%)

SNOW Snowflake
$166.28 /

-1.55 (-0.92%)

RIVN Rivian Automotive
$38.87 /

-0.04 (-0.10%)

OKTA Okta
$102.51 /

+0.11 (+0.11%)

NVS Novartis
$85.51 /

+0.065 (+0.08%)

LNG Cheniere Energy
$156.49 /

+1.82 (+1.18%)

LFC China Life Insurance
$7.30 /

-0.21 (-2.80%)

JNJ Johnson & Johnson
$166.17 /

-0.88 (-0.53%)

ILMN Illumina
$208.12 /

-19.52 (-8.57%)

IIVI II-VI
$52.77 /

+0.25 (+0.48%)

HSBC HSBC
$33.40 /

-0.1 (-0.30%)

CRM Salesforce
$187.47 /

+0.71 (+0.38%)

AIV Aimco
$9.63 /

+0.425 (+4.62%)

WDAY Workday
$174.90 /

+8.98 (+5.41%)

TOST Toast
$20.39 /

+2.265 (+12.50%)

SNY Sanofi
$44.19 /

+0.67 (+1.54%)

SNOW Snowflake
$166.28 /

-1.55 (-0.92%)

SMRT SmartRent
$3.78 /

-1.785 (-32.10%)

SIX Six Flags
$23.19 /

+2.07 (+9.80%)

RIVN Rivian Automotive
$38.87 /

-0.04 (-0.10%)

OKTA Okta
$102.51 /

+0.11 (+0.11%)

NVS Novartis
$85.51 /

+0.065 (+0.08%)

LZ LegalZoom
$13.24 /

+2.07 (+18.53%)

LNG Cheniere Energy
$156.49 /

+1.82 (+1.18%)

LAW CS Disco
$13.62 /

-15.345 (-52.99%)

JNJ Johnson & Johnson
$166.17 /

-0.88 (-0.53%)

ILMN Illumina
$208.12 /

-19.52 (-8.57%)

IIVI II-VI
$52.77 /

+0.25 (+0.48%)

HSBC HSBC
$33.40 /

-0.1 (-0.30%)

HNST Honest Company
$3.87 /

+0.035 (+0.91%)

ELF e.l.f. Beauty
$36.28 /

-0.15 (-0.41%)

CRM Salesforce
$187.47 /

+0.71 (+0.38%)

CIEN Ciena
$54.30 /

+1.4 (+2.65%)

WDAY Workday
$174.90 /

+8.98 (+5.41%)

TOST Toast
$20.39 /

+2.265 (+12.50%)

SNOW Snowflake
$166.28 /

-1.55 (-0.92%)

RIVN Rivian Automotive
$38.87 /

-0.04 (-0.10%)

PAYO Payoneer Global
$7.09 /

+1.405 (+24.74%)

OKTA Okta
$102.51 /

+0.11 (+0.11%)

NVS Novartis
$85.51 /

+0.065 (+0.08%)

LNG Cheniere Energy
$156.49 /

+1.82 (+1.18%)

JNJ Johnson & Johnson
$166.17 /

-0.88 (-0.53%)

ILMN Illumina
$208.12 /

-19.52 (-8.57%)

HSBC HSBC
$33.40 /

-0.1 (-0.30%)

HNST Honest Company
$3.87 /

+0.035 (+0.91%)

CRM Salesforce
$187.47 /

+0.71 (+0.38%)

BR Broadridge
$178.16 /

+8.485 (+5.00%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:34
08/12/22
08/12
09:34
08/12/22
09:34
CIEN

Ciena

$52.90 /

-1.08 (-2.00%)

, PRQR

ProQR Therapeutics

/

+

, CNTA

Centessa

$4.27 /

-0.43 (-9.15%)

, SIX

Six Flags

$21.12 /

-4.685 (-18.16%)

, OLO

Olo

$13.00 /

-0.235 (-1.78%)

, LAW

CS Disco

$28.96 /

+0.39 (+1.37%)

, ELF

e.l.f. Beauty

$36.44 /

-0.02 (-0.05%)

, MSFT

Microsoft

$287.35 /

-1.82 (-0.63%)

, GDRX

GoodRx

$7.60 /

+0.205 (+2.77%)

, MREO

Mereo BioPharma

$1.15 /

-0.055 (-4.56%)

, BB

BlackBerry

$6.73 /

-0.185 (-2.68%)

, ADM

Archer Daniels

$84.14 /

+0.53 (+0.63%)

, LNT

Alliant Energy

$61.67 /

-0.295 (-0.48%)

, SNY

Sanofi

$43.46 /

-1.74 (-3.85%)

, SAFE

Safehold

$45.32 /

+1.88 (+4.33%)

Institutional investors…

ShowHide Related Items >><<
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SIX Six Flags
$21.12 /

-4.685 (-18.16%)

SAFE Safehold
$45.32 /

+1.88 (+4.33%)

PRQR ProQR Therapeutics
/

+

OLO Olo
$13.00 /

-0.235 (-1.78%)

MSFT Microsoft
$287.35 /

-1.82 (-0.63%)

MREO Mereo BioPharma
$1.15 /

-0.055 (-4.56%)

LNT Alliant Energy
$61.67 /

-0.295 (-0.48%)

LAW CS Disco
$28.96 /

+0.39 (+1.37%)

GDRX GoodRx
$7.60 /

+0.205 (+2.77%)

ELF e.l.f. Beauty
$36.44 /

-0.02 (-0.05%)

CNTA Centessa
$4.27 /

-0.43 (-9.15%)

CIEN Ciena
$52.90 /

-1.08 (-2.00%)

BB BlackBerry
$6.73 /

-0.185 (-2.68%)

ADM Archer Daniels
$84.14 /

+0.53 (+0.63%)

CIEN Ciena
$52.90 /

-1.08 (-2.00%)

08/12/22 Morgan Stanley
Ciena upgraded to Overweight at Morgan Stanley as supply chain improves
08/12/22 Morgan Stanley
Ciena upgraded to Overweight from Equal Weight at Morgan Stanley
08/04/22 MKM Partners
Ciena assumed with a Buy at MKM Partners
07/14/22 JPMorgan
Ciena price target lowered to $62 from $72 at JPMorgan
PRQR ProQR Therapeutics
/

+

08/12/22 Chardan
ProQR Therapeutics downgraded to Neutral from Buy at Chardan
08/11/22 Raymond James
ProQR upgraded to Outperform at Raymond James on RNA editing 'conviction'
08/11/22 Raymond James
ProQR Therapeutics upgraded to Outperform from Market Perform at Raymond James
05/12/22 Cantor Fitzgerald
ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald
CNTA Centessa
$4.27 /

-0.43 (-9.15%)

08/12/22 Morgan Stanley
Centessa double downgraded to Underweight from Overweight at Morgan Stanley
08/12/22 Morgan Stanley
Centessa downgraded to Underweight from Overweight at Morgan Stanley
08/11/22 BMO Capital
Centessa price target lowered to $11 from $19 at BMO Capital
06/16/22 BMO Capital
Centessa initiated with an Outperform at BMO Capital
SIX Six Flags
$21.12 /

-4.685 (-18.16%)

08/12/22 Deutsche Bank
Six Flags price target lowered to $38 from $56 at Deutsche Bank
08/12/22 Truist
Six Flags price target lowered to $20 from $32 at Truist
08/12/22 Stifel
Six Flags price target lowered to $28 from $35 at Stifel
08/12/22 KeyBanc
Six Flags downgraded to Sector Weight at KeyBanc after 'indefensible' Q2
OLO Olo
$13.00 /

-0.235 (-1.78%)

08/12/22 RBC Capital
Olo price target lowered to $12 from $17 at RBC Capital
08/12/22 Truist
Olo price target lowered to $16 from $25 at Truist
08/12/22 Piper Sandler
Olo downgraded to Neutral from Overweight at Piper Sandler
08/12/22 Stifel
Olo downgraded to Hold from Buy at Stifel
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

08/12/22 Canaccord
CS Disco downgraded to Hold at Canaccord as estimates get reset
08/12/22 Stifel
CS Disco price target lowered to $30 from $40 at Stifel
08/12/22 BofA
CS Disco downgraded to Neutral from Buy at BofA
08/12/22 Canaccord
CS Disco downgraded to Hold from Buy at Canaccord
ELF e.l.f. Beauty
$36.44 /

-0.02 (-0.05%)

08/12/22 Cowen
e.l.f. Beauty downgraded to Market Perform at Cowen on valuation
08/12/22 Cowen
e.l.f. Beauty downgraded to Market Perform from Outperform at Cowen
08/04/22 Truist
e.l.f. Beauty price target raised to $40 from $35 at Truist
07/21/22 JPMorgan
e.l.f. Beauty price target raised to $35 from $30 at JPMorgan
MSFT Microsoft
$287.35 /

-1.82 (-0.63%)

08/11/22 Guggenheim
Microsoft initiated with a Neutral at Guggenheim
08/08/22 B. Riley
B. Riley thinks Globalstar's mystery satellite capacity customer is Apple
08/04/22 MKM Partners
8x8 initiated with a Neutral at MKM Partners
08/04/22 Deutsche Bank
Activision Blizzard price target lowered to $84 from $95 at Deutsche Bank
GDRX GoodRx
$7.60 /

+0.205 (+2.77%)

08/11/22 DA Davidson
GoodRx initiated with a Neutral at DA Davidson
08/09/22 Goldman Sachs
Goldman Sachs raises GoodRx price target to $10 amid grocer issue resolution
08/09/22 RBC Capital
GoodRx price target raised to $11 from $6.50 at RBC Capital
08/09/22 Barclays
GoodRx price target raised to $13 from $12 at Barclays
MREO Mereo BioPharma
$1.15 /

-0.055 (-4.56%)

08/12/22 Cantor Fitzgerald
Mereo BioPharma initiated with an Overweight at Cantor Fitzgerald
06/06/22 Needham
Mereo BioPharma price target lowered to $5 from $10 at Needham
BB BlackBerry
$6.73 /

-0.185 (-2.68%)

08/12/22 Baird
BlackBerry initiated with a Neutral at Baird
06/24/22 TD Securities
TD Securities cuts BlackBerry target to $5 after 'low-quality' beat
05/19/22 Canaccord
BlackBerry price target lowered to $6 from $7 at Canaccord
04/01/22 Canaccord
BlackBerry results in-line but guidance disappoints, says Canaccord
ADM Archer Daniels
$84.14 /

+0.53 (+0.63%)

08/12/22 Wolfe Research
Wolfe Research starts Archer Daniels at Outperform on 'competitive' dividend
08/11/22 Wolfe Research
Archer Daniels initiated with an Outperform at Wolfe Research
07/27/22 Baird
Archer Daniels price target raised to $94 from $87 at Baird
06/30/22 BofA
Bunge upgraded to Buy from Neutral at BofA
LNT Alliant Energy
$61.67 /

-0.295 (-0.48%)

08/12/22 BofA
BofA upgrades 'IRA winner' Alliant Energy to Buy
08/12/22 BofA
Alliant Energy upgraded to Buy from Neutral at BofA
08/08/22 BofA
Alliant Energy price target raised to $62 from $57 at BofA
07/18/22 Barclays
Alliant Energy price target lowered to $62 from $68 at Barclays
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

08/12/22 Deutsche Bank
Deutsche Bank raises Sanofi to Hold, calls Zantac 'knee-jerk' reaction overdone
08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
08/12/22 Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
SAFE Safehold
$45.32 /

+1.88 (+4.33%)

08/12/22 Mizuho
Safehold upgraded to Buy from Neutral at Mizuho
08/11/22 Truist
iStar tax-free combination to internalize Safehold management team, says Truist
07/15/22 Morgan Stanley
Safehold price target lowered to $85 from $100 at Morgan Stanley
06/28/22 B. Riley
B. Riley says buy iStar into expected merger with Safehold
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SIX Six Flags
$21.12 /

-4.685 (-18.16%)

SAFE Safehold
$45.32 /

+1.88 (+4.33%)

PRQR ProQR Therapeutics
/

+

OLO Olo
$13.00 /

-0.235 (-1.78%)

MSFT Microsoft
$287.35 /

-1.82 (-0.63%)

LNT Alliant Energy
$61.67 /

-0.295 (-0.48%)

LAW CS Disco
$28.96 /

+0.39 (+1.37%)

GDRX GoodRx
$7.60 /

+0.205 (+2.77%)

ELF e.l.f. Beauty
$36.44 /

-0.02 (-0.05%)

CNTA Centessa
$4.27 /

-0.43 (-9.15%)

CIEN Ciena
$52.90 /

-1.08 (-2.00%)

BB BlackBerry
$6.73 /

-0.185 (-2.68%)

ADM Archer Daniels
$84.14 /

+0.53 (+0.63%)

  • 03
    Mar
  • 23
    Sep
  • 15
    Sep
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

MSFT Microsoft
$287.35 /

-1.82 (-0.63%)

MREO Mereo BioPharma
$1.15 /

-0.055 (-4.56%)

ADM Archer Daniels
$84.14 /

+0.53 (+0.63%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SIX Six Flags
$21.12 /

-4.685 (-18.16%)

OLO Olo
$13.00 /

-0.235 (-1.78%)

MSFT Microsoft
$287.35 /

-1.82 (-0.63%)

LAW CS Disco
$28.96 /

+0.39 (+1.37%)

GDRX GoodRx
$7.60 /

+0.205 (+2.77%)

ELF e.l.f. Beauty
$36.44 /

-0.02 (-0.05%)

CIEN Ciena
$52.90 /

-1.08 (-2.00%)

BB BlackBerry
$6.73 /

-0.185 (-2.68%)

ADM Archer Daniels
$84.14 /

+0.53 (+0.63%)

MSFT Microsoft
$287.35 /

-1.82 (-0.63%)

GDRX GoodRx
$7.60 /

+0.205 (+2.77%)

CNTA Centessa
$4.27 /

-0.43 (-9.15%)

BB BlackBerry
$6.73 /

-0.185 (-2.68%)

ADM Archer Daniels
$84.14 /

+0.53 (+0.63%)

Upgrade
Deutsche Bank raises Sanofi to Hold, calls Zantac 'knee-jerk' reaction overdone » 08:15
08/12/22
08/12
08:15
08/12/22
08:15
SNY

Sanofi

$43.46 /

-1.74 (-3.85%)

As previously reported,…

As previously reported, Deutsche Bank analyst Emmanuel Papadakis upgraded Sanofi to Hold from Sell with an unchanged price target of EUR 90. The Zantac litigation "knee-jerk" reaction is "starting to look somewhat overdone" and although this doesn't "make for an obvious buying opportunity in our view," keeping a Sell rating on the stock at current levels "feels egregious," Papadakis tells investors.

ShowHide Related Items >><<
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
08/12/22 Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

Recommendations
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan » 07:40
08/12/22
08/12
07:40
08/12/22
07:40
SNY

Sanofi

$43.46 /

-1.74 (-3.85%)

, GSK

GSK plc

$35.75 /

-2.57 (-6.71%)

, HLN

Haleon

$6.29 /

-0.22 (-3.38%)

, PFE

Pfizer

$48.31 /

-1.62 (-3.24%)

JPMorgan analysts Richard…

JPMorgan analysts Richard Vosser and James Gordon note that shares of GSK plc (GSK), Sanofi (SNY), Haleon (HLN) and Pfizer (PFE) have lost a combined market cap of $44B week to date, which they attribute largely to concerns around potential liabilities related to Zantac litigation. They believe the magnitude of this week's market cap hit "likely exceeds even a worst-case scenario" and also believe the market has not fairly attributed any potential Zantac liability between the various companies involved, the analysts tell investors. GSK is likely to have the clearest evidence linking Zantac use to individual named patients given that it sold the product on a prescription basis from 1983, but they still see this week's $12B hit to the company's market cap as a "potential over-reaction." Still, Vosser and Gordon state in their note that they don't see the GSK overhang shifting ahead of the first bellweather case being heard this coming February. In contrast, they believe it is possible that Sanofi may not be liable for any litigation damages given the company's indemnification agreement with Boehringer that is currently under arbitration. Even in the event Sanofi is not fully indemnified, their exposure via OTC sales would likely be lower than GSK and the company's $16.5B loss in market cap this week means an "overly bearish Zantac outlook is now likely priced in," the analysts said. The firm has an Overweight rating on Sanofi shares and a Neutral rating on GSK.

ShowHide Related Items >><<
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

08/12/22 Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 UBS
Sanofi downgraded to Neutral from Buy at UBS
GSK GSK plc
$35.75 /

-2.57 (-6.71%)

08/09/22 Baird
Mersana Therapeutics price target raised to $20 from $18 at Baird
08/08/22 UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
HLN Haleon
$6.29 /

-0.22 (-3.38%)

07/29/22 Deutsche Bank
Haleon initiated with a Hold at Deutsche Bank
07/25/22 Goldman Sachs
Haleon initiated with a Buy at Goldman Sachs (last week)
PFE Pfizer
$48.31 /

-1.62 (-3.24%)

08/09/22 Wells Fargo
Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

Upgrade
Sanofi upgraded to Hold from Sell at Deutsche Bank » 05:33
08/12/22
08/12
05:33
08/12/22
05:33
SNY

Sanofi

$43.46 /

-1.74 (-3.85%)

Deutsche Bank analyst…

Deutsche Bank analyst Emmanuel Papadakis upgraded Sanofi to Hold from Sell with an unchanged price target of EUR 90.

ShowHide Related Items >><<
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 UBS
Sanofi downgraded to Neutral from Buy at UBS
08/05/22 Stifel
Sanofi price target raised to EUR 119 from EUR 115 at Stifel
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

Thursday
On The Fly
What You Missed On Wall Street On Thursday » 16:40
08/11/22
08/11
16:40
08/11/22
16:40
SAFE

Safehold

$45.32 /

+1.88 (+4.33%)

, STAR

iStar

$15.72 /

-1.365 (-7.99%)

, DIS

Disney

$117.68 /

+5.12 (+4.55%)

, SONO

Sonos

$17.09 /

-5.685 (-24.97%)

, APP

AppLovin

$34.46 /

-6.01 (-14.85%)

, BMBL

Bumble

$31.53 /

-2.93 (-8.50%)

, DE

Deere

$361.92 /

+9.59 (+2.72%)

, FSLR

First Solar

$114.56 /

+0.05 (+0.04%)

, LOW

Lowe's

$202.15 /

+0.68 (+0.34%)

, SHOP

Shopify

$40.44 /

-0.135 (-0.33%)

, MCD

McDonald's

$259.22 /

-2.08 (-0.80%)

, CS

Credit Suisse

$5.72 /

+0.045 (+0.79%)

, SFTBY

SoftBank Group

$20.50 /

+0.1 (+0.49%)

, SNAP

Snap

$11.11 /

+0.54 (+5.11%)

, HOOD

Robinhood

$10.51 /

-0.08 (-0.76%)

, RGEN

Repligen

$246.53 /

-8.47 (-3.32%)

, CTLT

Catalent

$109.93 /

-2.92 (-2.59%)

, MTTR

Matterport

$5.99 /

+0.795 (+15.32%)

, NYT

New York Times

$35.06 /

+3.365 (+10.62%)

, SNY

Sanofi

$43.46 /

-1.74 (-3.85%)

, GSK

GSK plc

$35.75 /

-2.57 (-6.71%)

, CERE

Cerevel Therapeutics

$35.75 /

-5.615 (-13.58%)

, SIX

Six Flags

$21.12 /

-4.685 (-18.16%)

, VCSA

Vacasa

$4.04 /

+1.03 (+34.22%)

, WRBY

Warby Parker

$16.89 /

+2.765 (+19.58%)

, MQ

Marqeta

$8.34 /

-2.705 (-24.50%)

, CIR

Circor

$19.06 /

+1.095 (+6.10%)

, MOGO

Mogo

$1.24 /

-0.13 (-9.49%)

Get caught up quickly on…

ShowHide Related Items >><<
WRBY Warby Parker
$16.89 /

+2.765 (+19.58%)

VCSA Vacasa
$4.04 /

+1.03 (+34.22%)

SONO Sonos
$17.09 /

-5.685 (-24.97%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SNAP Snap
$11.11 /

+0.54 (+5.11%)

SIX Six Flags
$21.12 /

-4.685 (-18.16%)

SHOP Shopify
$40.44 /

-0.135 (-0.33%)

SFTBY SoftBank Group
$20.50 /

+0.1 (+0.49%)

SAFE Safehold
$45.32 /

+1.88 (+4.33%)

RGEN Repligen
$246.53 /

-8.47 (-3.32%)

NYT New York Times
$35.06 /

+3.365 (+10.62%)

MTTR Matterport
$5.99 /

+0.795 (+15.32%)

MQ Marqeta
$8.34 /

-2.705 (-24.50%)

MOGO Mogo
$1.24 /

-0.13 (-9.49%)

MCD McDonald's
$259.22 /

-2.08 (-0.80%)

LOW Lowe's
$202.15 /

+0.68 (+0.34%)

HOOD Robinhood
$10.51 /

-0.08 (-0.76%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

FSLR First Solar
$114.56 /

+0.05 (+0.04%)

DIS Disney
$117.68 /

+5.12 (+4.55%)

DE Deere
$361.92 /

+9.59 (+2.72%)

CTLT Catalent
$109.93 /

-2.92 (-2.59%)

CS Credit Suisse
$5.72 /

+0.045 (+0.79%)

CIR Circor
$19.06 /

+1.095 (+6.10%)

CERE Cerevel Therapeutics
$35.75 /

-5.615 (-13.58%)

BMBL Bumble
$31.53 /

-2.93 (-8.50%)

APP AppLovin
$34.46 /

-6.01 (-14.85%)

SAFE Safehold
$45.32 /

+1.88 (+4.33%)

08/11/22 Truist
iStar tax-free combination to internalize Safehold management team, says Truist
07/15/22 Morgan Stanley
Safehold price target lowered to $85 from $100 at Morgan Stanley
06/28/22 B. Riley
B. Riley says buy iStar into expected merger with Safehold
05/24/22 Raymond James
iStar price target lowered to $21 from $33 at Raymond James
STAR iStar
$15.72 /

-1.365 (-7.99%)

01/03/22 B. Riley
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022
DIS Disney
$117.68 /

+5.12 (+4.55%)

08/11/22 Credit Suisse
Disney price target lowered to $157 from $170 at Credit Suisse
08/11/22 JPMorgan
Disney price target lowered to $160 from $175 at JPMorgan
08/11/22 KeyBanc
Disney price target raised to $154 from $131 at KeyBanc
08/11/22 Wells Fargo
Disney price target raised to $145 from $130 at Wells Fargo
SONO Sonos
$17.09 /

-5.685 (-24.97%)

08/11/22 Morgan Stanley
Sonos price target lowered to $20 from $28 at Morgan Stanley
08/11/22 Stifel
Sonos price target lowered to $20 from $24 at Stifel
06/14/22 Morgan Stanley
Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures
06/14/22 Morgan Stanley
Sonos downgraded to Equal Weight from Overweight at Morgan Stanley
APP AppLovin
$34.46 /

-6.01 (-14.85%)

08/11/22 BTIG
AppLovin price target lowered to $53 from $60 at BTIG
08/11/22 Truist
AppLovin price target lowered to $65 from $77 at Truist
08/11/22 Credit Suisse
ironSource downgraded to Neutral from Outperform at Credit Suisse
08/10/22 Citi
AppLovin bid for Unity faces 'several challenges,' says Citi
BMBL Bumble
$31.53 /

-2.93 (-8.50%)

08/11/22 Susquehanna
Bumble price target raised to $36 from $24 at Susquehanna
08/11/22 RBC Capital
Bumble price target raised to $33 from $30 at RBC Capital
08/11/22 Piper Sandler
Bumble price target raised to $30 from $21 at Piper Sandler
08/01/22 Jefferies
Bumble downgraded to Hold from Buy at Jefferies
DE Deere
$361.92 /

+9.59 (+2.72%)

08/11/22 Deutsche Bank
Deere price target lowered to $388 from $417 at Deutsche Bank
08/11/22 Evercore ISI
Deere upgraded to Outperform from In Line at Evercore ISI
07/18/22 Oppenheimer
Deere price target lowered to $365 from $419 at Oppenheimer
07/15/22 Jefferies
Deere price target lowered to $400 from $450 at Jefferies
FSLR First Solar
$114.56 /

+0.05 (+0.04%)

08/11/22 KeyBanc
KeyBanc upgrades First Solar to Overweight, sets $145 price target
08/11/22 KeyBanc
First Solar upgraded to Overweight from Sector Weight at KeyBanc
08/08/22 JPMorgan
First Solar upgraded to Overweight from Neutral at JPMorgan
08/08/22 Guggenheim
First Solar upgraded to Buy at Guggenheim on confidence in passage of IRA act
LOW Lowe's
$202.15 /

+0.68 (+0.34%)

08/11/22 Citi
Lowe's downgraded to Neutral from Buy at Citi
08/09/22 JPMorgan
Lowe's price target lowered to $210 from $230 at JPMorgan
08/03/22 Wells Fargo
Lowe's price target lowered to $220 from $240 at Wells Fargo
06/22/22 MKM Partners
Lowe's initiated with a Neutral at MKM Partners
SHOP Shopify
$40.44 /

-0.135 (-0.33%)

08/11/22 Atlantic Equities
Atlantic upgrades 'market leader' in innovation Shopify to Overweight
08/11/22 Atlantic Equities
Shopify upgraded to Overweight from Neutral at Atlantic Equities
08/10/22 DZ Bank
Shopify downgraded to Hold from Buy at DZ Bank
08/05/22 KGI Securities
Shopify downgraded to Neutral from Outperform at KGI Securities
MCD McDonald's
$259.22 /

-2.08 (-0.80%)

07/28/22 JPMorgan
Beyond Meat burger at McDonalds in U.S. is 'McDone,' says JPMorgan
07/27/22 RBC Capital
McDonald's price target raised to $305 from $292 at RBC Capital
07/27/22 Barclays
McDonald's price target lowered to $285 from $289 at Barclays
07/27/22 Citi
McDonald's price target raised to $275 from $266 at Citi
CS Credit Suisse
$5.72 /

+0.045 (+0.79%)

08/03/22 Berenberg
Credit Suisse price target lowered to CHF 7 from CHF 8 at Berenberg
08/02/22 Goldman Sachs
Credit Suisse downgraded to Sell from Neutral at Goldman Sachs
07/28/22 Barclays
Credit Suisse price target lowered to CHF 4 from CHF 5 at Barclays
07/28/22 Morgan Stanley
Credit Suisse price target lowered to CHF 6 from CHF 6.60 at Morgan Stanley
SFTBY SoftBank Group
$20.50 /

+0.1 (+0.49%)

02/08/22 Citi
Street largely expected Nvidia deal to fall through, says Citi
02/07/22 Citi
Alibaba filing may suggest Softbank intention to sell shares, says Citi
SNAP Snap
$11.11 /

+0.54 (+5.11%)

07/27/22 Jefferies
Alphabet price target lowered to $130 from $155 at Jefferies
07/27/22 Morgan Stanley
Alphabet price target raised to $145 from $140 at Morgan Stanley
07/25/22 Argus
Snap downgraded to Hold from Buy at Argus
07/25/22 MoffettNathanson
Snap downgraded to Market Perform at MoffettNathanson (Friday)
HOOD Robinhood
$10.51 /

-0.08 (-0.76%)

08/04/22 Deutsche Bank
Robinhood price target raised to $9 from $8 at Deutsche Bank
08/04/22 Mizuho
Robinhood price target lowered to $13 from $14 at Mizuho
08/03/22 Piper Sandler
Robinhood price target lowered to $10 from $11 at Piper Sandler
07/25/22 JPMorgan
JPMorgan sees increased share dilution risk for Coinbase, Robinhood
RGEN Repligen
$246.53 /

-8.47 (-3.32%)

07/20/22 UBS
Repligen initiated with a Buy at UBS
04/28/22 Craig-Hallum
Repligen price target lowered to $274 from $286 at Craig-Hallum
02/18/22 SVB Securities
Repligen price target lowered to $250 from $275 at SVB Leerink
11/26/21 Benchmark
Recent deals highlight value in ImmunoPrecise shares, says Benchmark
CTLT Catalent
$109.93 /

-2.92 (-2.59%)

07/13/22 Barclays
Avantor price target lowered to $37 from $40 at Barclays
04/12/22 Deutsche Bank
Catalent price target lowered to $110 from $129 at Deutsche Bank
02/02/22 Deutsche Bank
Catalent price target lowered to $129 from $164 at Deutsche Bank
01/27/22 Barclays
Catalent price target lowered to $130 from $160 at Barclays
MTTR Matterport
$5.99 /

+0.795 (+15.32%)

08/11/22 Piper Sandler
Matterport price target raised to $7 from $5 at Piper Sandler
07/18/22 Piper Sandler
Matterport price target lowered to $5 from $7 at Piper Sandler
07/14/22 Morgan Stanley
Matterport price target lowered to $5 from $6 at Morgan Stanley
05/11/22 Deutsche Bank
Matterport price target lowered to $7 from $9 at Deutsche Bank
NYT New York Times
$35.06 /

+3.365 (+10.62%)

08/11/22 Gordon Haskett
New York Times share buys at UBS flagged by Gordon Haskett on activist link
08/04/22 Morgan Stanley
New York Times price target lowered to $37 from $40 at Morgan Stanley
07/21/22 Guggenheim
New York Times price target lowered to $34 from $41 at Guggenheim
06/22/22 Cannonball Research
'Not right market for' NYT story, Cannonball Research says in downgrade
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

08/12/22 Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 UBS
Sanofi downgraded to Neutral from Buy at UBS
GSK GSK plc
$35.75 /

-2.57 (-6.71%)

08/09/22 Baird
Mersana Therapeutics price target raised to $20 from $18 at Baird
08/08/22 UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
CERE Cerevel Therapeutics
$35.75 /

-5.615 (-13.58%)

08/08/22 Stifel
Cerevel Therapeutics price target raised to $54 from $50 at Stifel
08/03/22 Mizuho
Cerevel Therapeutics price target lowered to $27 from $30 at Mizuho
07/06/22 Mizuho
Cerevel Therapeutics initiated with a Neutral at Mizuho
02/14/22 Goldman Sachs
Cerevel Therapeutics initiated with a Neutral at Goldman Sachs
SIX Six Flags
$21.12 /

-4.685 (-18.16%)

08/11/22 KeyBanc
Six Flags downgraded to Sector Weight from Overweight at KeyBanc
07/08/22 Citi
Six Flags downgraded to Neutral from Buy at Citi
06/24/22 Stifel
Six Flags price target lowered to $35 from $52 at Stifel
06/21/22 B. Riley
Six Flags downgraded to Neutral from Buy at B. Riley
VCSA Vacasa
$4.04 /

+1.03 (+34.22%)

06/29/22 JPMorgan
Vacasa price target lowered to $6 from $9 at JPMorgan
06/09/22 Goldman Sachs
Vacasa price target lowered to $5.50 from $9 at Goldman Sachs
06/09/22 JMP Securities
Vacasa assumed with an Outperform at JMP Securities
03/29/22 KeyBanc
End-market data analysis suggests consumer travel holding up well, says KeyBanc
WRBY Warby Parker
$16.89 /

+2.765 (+19.58%)

07/22/22 Piper Sandler
Warby Parker initiated with an Overweight at Piper Sandler
07/21/22 Goldman Sachs
Warby Parker price target lowered to $12 from $16 at Goldman Sachs
07/20/22 Stifel
Warby Parker price target lowered to $11 from $15 at Stifel
06/27/22 Loop Capital
Warby Parker price target lowered to $15 from $18 at Loop Capital
MQ Marqeta
$8.34 /

-2.705 (-24.50%)

08/11/22 Wells Fargo
Wells Fargo downgrades Marqeta to Equal Weight, lowers price target to $11
08/11/22 Wells Fargo
Marqeta downgraded to Equal Weight from Overweight at Wells Fargo
08/04/22 Truist
Marqeta weakness on FIS confusion a buying opportunity, says Truist
08/04/22 KeyBanc
FIS win with Block not infringing on Marqeta relationship, says KeyBanc
CIR Circor
$19.06 /

+1.095 (+6.10%)

08/11/22 KeyBanc
Circor price target lowered to $27 from $37 at KeyBanc
04/18/22 Stifel
Circor price target lowered to $36 from $41 at Stifel
01/20/22 Stifel
Circor path to shareholder value 'clearer and cleaner' via sale, says Stifel
MOGO Mogo
$1.24 /

-0.13 (-9.49%)

05/13/22 Raymond James
Mogo price target lowered to C$4 from C$8 at Raymond James
05/13/22 H.C. Wainwright
Mogo price target lowered to $4 from $8 at H.C. Wainwright
03/24/22 Canaccord
Mogo price target lowered to C$7 from C$10 at Canaccord
03/09/22 Raymond James
Mogo price target lowered to C$8 from C$13.50 at Raymond James
WRBY Warby Parker
$16.89 /

+2.765 (+19.58%)

VCSA Vacasa
$4.04 /

+1.03 (+34.22%)

STAR iStar
$15.72 /

-1.365 (-7.99%)

SONO Sonos
$17.09 /

-5.685 (-24.97%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SNAP Snap
$11.11 /

+0.54 (+5.11%)

SIX Six Flags
$21.12 /

-4.685 (-18.16%)

SHOP Shopify
$40.44 /

-0.135 (-0.33%)

SFTBY SoftBank Group
$20.50 /

+0.1 (+0.49%)

SAFE Safehold
$45.32 /

+1.88 (+4.33%)

RGEN Repligen
$246.53 /

-8.47 (-3.32%)

NYT New York Times
$35.06 /

+3.365 (+10.62%)

MTTR Matterport
$5.99 /

+0.795 (+15.32%)

MQ Marqeta
$8.34 /

-2.705 (-24.50%)

MOGO Mogo
$1.24 /

-0.13 (-9.49%)

MCD McDonald's
$259.22 /

-2.08 (-0.80%)

LOW Lowe's
$202.15 /

+0.68 (+0.34%)

HOOD Robinhood
$10.51 /

-0.08 (-0.76%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

FSLR First Solar
$114.56 /

+0.05 (+0.04%)

DIS Disney
$117.68 /

+5.12 (+4.55%)

DE Deere
$361.92 /

+9.59 (+2.72%)

CTLT Catalent
$109.93 /

-2.92 (-2.59%)

CS Credit Suisse
$5.72 /

+0.045 (+0.79%)

CIR Circor
$19.06 /

+1.095 (+6.10%)

CERE Cerevel Therapeutics
$35.75 /

-5.615 (-13.58%)

BMBL Bumble
$31.53 /

-2.93 (-8.50%)

APP AppLovin
$34.46 /

-6.01 (-14.85%)

  • 12
    Aug
  • 03
    Mar
  • 03
    Dec
  • 23
    Sep
  • 29
    Sep
  • 10
    Sep
WRBY Warby Parker
$16.89 /

+2.765 (+19.58%)

SONO Sonos
$17.09 /

-5.685 (-24.97%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SNAP Snap
$11.11 /

+0.54 (+5.11%)

SHOP Shopify
$40.44 /

-0.135 (-0.33%)

SFTBY SoftBank Group
$20.50 /

+0.1 (+0.49%)

RGEN Repligen
$246.53 /

-8.47 (-3.32%)

NYT New York Times
$35.06 /

+3.365 (+10.62%)

MCD McDonald's
$259.22 /

-2.08 (-0.80%)

LOW Lowe's
$202.15 /

+0.68 (+0.34%)

HOOD Robinhood
$10.51 /

-0.08 (-0.76%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

FSLR First Solar
$114.56 /

+0.05 (+0.04%)

DIS Disney
$117.68 /

+5.12 (+4.55%)

DE Deere
$361.92 /

+9.59 (+2.72%)

CS Credit Suisse
$5.72 /

+0.045 (+0.79%)

BMBL Bumble
$31.53 /

-2.93 (-8.50%)

APP AppLovin
$34.46 /

-6.01 (-14.85%)

WRBY Warby Parker
$16.89 /

+2.765 (+19.58%)

STAR iStar
$15.72 /

-1.365 (-7.99%)

SONO Sonos
$17.09 /

-5.685 (-24.97%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

SNAP Snap
$11.11 /

+0.54 (+5.11%)

SIX Six Flags
$21.12 /

-4.685 (-18.16%)

SHOP Shopify
$40.44 /

-0.135 (-0.33%)

SFTBY SoftBank Group
$20.50 /

+0.1 (+0.49%)

SAFE Safehold
$45.32 /

+1.88 (+4.33%)

NYT New York Times
$35.06 /

+3.365 (+10.62%)

MOGO Mogo
$1.24 /

-0.13 (-9.49%)

MCD McDonald's
$259.22 /

-2.08 (-0.80%)

LOW Lowe's
$202.15 /

+0.68 (+0.34%)

HOOD Robinhood
$10.51 /

-0.08 (-0.76%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

DIS Disney
$117.68 /

+5.12 (+4.55%)

DE Deere
$361.92 /

+9.59 (+2.72%)

CS Credit Suisse
$5.72 /

+0.045 (+0.79%)

APP AppLovin
$34.46 /

-6.01 (-14.85%)

WRBY Warby Parker
$16.89 /

+2.765 (+19.58%)

VCSA Vacasa
$4.04 /

+1.03 (+34.22%)

SONO Sonos
$17.09 /

-5.685 (-24.97%)

SNAP Snap
$11.11 /

+0.54 (+5.11%)

SHOP Shopify
$40.44 /

-0.135 (-0.33%)

MTTR Matterport
$5.99 /

+0.795 (+15.32%)

MQ Marqeta
$8.34 /

-2.705 (-24.50%)

MCD McDonald's
$259.22 /

-2.08 (-0.80%)

LOW Lowe's
$202.15 /

+0.68 (+0.34%)

HOOD Robinhood
$10.51 /

-0.08 (-0.76%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

FSLR First Solar
$114.56 /

+0.05 (+0.04%)

DIS Disney
$117.68 /

+5.12 (+4.55%)

DE Deere
$361.92 /

+9.59 (+2.72%)

CTLT Catalent
$109.93 /

-2.92 (-2.59%)

CS Credit Suisse
$5.72 /

+0.045 (+0.79%)

BMBL Bumble
$31.53 /

-2.93 (-8.50%)

APP AppLovin
$34.46 /

-6.01 (-14.85%)

Recommendations
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan » 14:50
08/11/22
08/11
14:50
08/11/22
14:50
PRGO

Perrigo

$41.26 /

-0.475 (-1.14%)

, PFE

Pfizer

$48.11 /

-1.82 (-3.65%)

, SNY

Sanofi

$43.79 /

-1.41 (-3.12%)

, GSK

GSK plc

$35.32 /

-2.995 (-7.82%)

, HLN

Haleon

$6.24 /

-0.275 (-4.22%)

JPMorgan analyst Chris…

JPMorgan analyst Chris Schott notes the refocus on Zantac liability that has emerged this week, and driven shares of GSK plc (GSK) and Sanofi (SNY) lower, and says he has been getting a number of questions on potential implications within his coverage, namely regarding Perrigo (PRGO) and Pfizer (PFE). As a store brand manufacturer, Perrigo's preemption and HatchWaxman defenses are "very strong," the company has been dismissed from one federal MDL litigation and is not named in the upcoming Madison IL trial, so he does not see Zantac litigation as a significant risk for Perrigo, Schott tells investors. Pfizer sold its rights to Zantac in 2006 and appears to be "at least partially indemnified" from any liability here by Haleon (HLN), said Schott, who contends that the company's loss of about $10B in market cap on this issue "seems overdone" relative to Pfizer's potential exposure. Schott has an Overweight rating on Perrigo shares and a Neutral rating on Pfizer.

ShowHide Related Items >><<
SNY Sanofi
$43.79 /

-1.41 (-3.12%)

PRGO Perrigo
$41.26 /

-0.475 (-1.14%)

PFE Pfizer
$48.11 /

-1.82 (-3.65%)

HLN Haleon
$6.24 /

-0.275 (-4.22%)

GSK GSK plc
$35.32 /

-2.995 (-7.82%)

PRGO Perrigo
$41.26 /

-0.475 (-1.14%)

05/31/22 Jefferies
Perrigo transferred with a Buy at Jefferies
11/11/21 Raymond James
Perrigo price target lowered to $55 from $59 at Raymond James
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 Raymond James
Raymond James upgrades Perrigo to buy on HRA deal, tax settlement
PFE Pfizer
$48.11 /

-1.82 (-3.65%)

08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 Wells Fargo
Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
08/08/22 Oppenheimer
Global Blood Therapeutics downgraded to Perform from Outperform at Oppenheimer
SNY Sanofi
$43.79 /

-1.41 (-3.12%)

08/09/22 UBS
Sanofi downgraded to Neutral from Buy at UBS
08/05/22 Stifel
Sanofi price target raised to EUR 119 from EUR 115 at Stifel
07/29/22 JPMorgan
Sanofi price target raised to EUR 115 from EUR 105 at JPMorgan
GSK GSK plc
$35.32 /

-2.995 (-7.82%)

08/09/22 Baird
Mersana Therapeutics price target raised to $20 from $18 at Baird
08/08/22 UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
08/05/22 Morgan Stanley
GSK plc resumed with an Equal Weight at Morgan Stanley
HLN Haleon
$6.24 /

-0.275 (-4.22%)

07/29/22 Deutsche Bank
Haleon initiated with a Hold at Deutsche Bank
07/25/22 Goldman Sachs
Haleon initiated with a Buy at Goldman Sachs (last week)
07/25/22 Credit Suisse
Haleon initiated with an Outperform at Credit Suisse (last week)
SNY Sanofi
$43.79 /

-1.41 (-3.12%)

PRGO Perrigo
$41.26 /

-0.475 (-1.14%)

PFE Pfizer
$48.11 /

-1.82 (-3.65%)

GSK GSK plc
$35.32 /

-2.995 (-7.82%)

SNY Sanofi
$43.79 /

-1.41 (-3.12%)

PRGO Perrigo
$41.26 /

-0.475 (-1.14%)

PFE Pfizer
$48.11 /

-1.82 (-3.65%)

GSK GSK plc
$35.32 /

-2.995 (-7.82%)

SNY Sanofi
$43.79 /

-1.41 (-3.12%)

PFE Pfizer
$48.11 /

-1.82 (-3.65%)

HLN Haleon
$6.24 /

-0.275 (-4.22%)

GSK GSK plc
$35.32 /

-2.995 (-7.82%)

PFE Pfizer
$48.11 /

-1.82 (-3.65%)

HLN Haleon
$6.24 /

-0.275 (-4.22%)

GSK GSK plc
$35.32 /

-2.995 (-7.82%)

On The Fly
Renewed Zantac litigation concerns sinking these big-cap drugmakers » 13:35
08/11/22
08/11
13:35
08/11/22
13:35
GSK

GSK plc

$34.82 /

-3.495 (-9.12%)

, SNY

Sanofi

$43.47 /

-1.73 (-3.83%)

, HLN

Haleon

$6.09 /

-0.42 (-6.45%)

, PFE

Pfizer

$48.21 /

-1.72 (-3.44%)

Shares of GSK plc (GSK),…

ShowHide Related Items >><<
SNY Sanofi
$43.47 /

-1.73 (-3.83%)

PFE Pfizer
$48.21 /

-1.72 (-3.44%)

HLN Haleon
$6.09 /

-0.42 (-6.45%)

GSK GSK plc
$34.82 /

-3.495 (-9.12%)

GSK GSK plc
$34.82 /

-3.495 (-9.12%)

08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 Baird
Mersana Therapeutics price target raised to $20 from $18 at Baird
SNY Sanofi
$43.47 /

-1.73 (-3.83%)

08/12/22 Deutsche Bank
Deutsche Bank raises Sanofi to Hold, calls Zantac 'knee-jerk' reaction overdone
08/12/22 Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
HLN Haleon
$6.09 /

-0.42 (-6.45%)

07/29/22 Deutsche Bank
Haleon initiated with a Hold at Deutsche Bank
PFE Pfizer
$48.21 /

-1.72 (-3.44%)

08/09/22 Wells Fargo
Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
SNY Sanofi
$43.47 /

-1.73 (-3.83%)

PFE Pfizer
$48.21 /

-1.72 (-3.44%)

GSK GSK plc
$34.82 /

-3.495 (-9.12%)

PFE Pfizer
$48.21 /

-1.72 (-3.44%)

GSK GSK plc
$34.82 /

-3.495 (-9.12%)

SNY Sanofi
$43.47 /

-1.73 (-3.83%)

PFE Pfizer
$48.21 /

-1.72 (-3.44%)

HLN Haleon
$6.09 /

-0.42 (-6.45%)

GSK GSK plc
$34.82 /

-3.495 (-9.12%)

PFE Pfizer
$48.21 /

-1.72 (-3.44%)

HLN Haleon
$6.09 /

-0.42 (-6.45%)

GSK GSK plc
$34.82 /

-3.495 (-9.12%)

Hot Stocks
Sanofi says 'confident in its legal defenses' related to U.S. Zantac litigation » 12:30
08/11/22
08/11
12:30
08/11/22
12:30
SNY

Sanofi

$43.24 /

-1.965 (-4.35%)

, GSK

GSK plc

$34.51 /

-3.805 (-9.93%)

, PFE

Pfizer

$48.08 /

-1.85 (-3.71%)

Sanofi issued the…

Sanofi issued the following media update: "In response to the recent highly speculative news flow regarding the U.S. Zantac litigation at a time when there have not been any material developments, Sanofi remains confident in its legal defenses and wishes to make the following statement, consistent with what has been disclosed previously: On September 13, 2019, FDA issued a statement alerting the public that some ranitidine medicines, including over-the-counter Zantac, contained a nitrosamine impurity called N-nitrosodimethylamine, or NDMA, at low levels. NDMA is a known environmental contaminant found in drinking water, soil, and common foods, including meats, dairy products, and vegetables. People are routinely exposed to small amounts of NDMA every day. FDA subsequently announced that its preliminary testing showed NDMA levels exceeded FDA's allowable limit in some of the samples it tested. Upon receipt of this information, however, Sanofi quickly mobilized, ran additional confirmatory testing, and out of an abundance of caution issued a voluntary recall of all ranitidine Zantac OTC products in the U.S. and Canada. Since 2019, the medical, scientific, and regulatory communities have extensively evaluated the safety of Zantac's active ingredient ranitidine, and the data shows there is no evidence of consumer harm from real-world use of Zantac. Over time, both FDA and the European Medicines Agency have evaluated the available data and found no evidence that ranitidine causes cancer. Regardless of the scientific evidence, within days of FDA's 2019 announcement, purported class actions and personal injury lawsuits were filed in US courts, seeking economic damages or alleging that Zantac caused various cancers. However, given that Sanofi acted responsibly at all times and the lack of scientific support for plaintiffs' claims, Sanofi is fully confident in its defenses to the litigation. Sanofi stands by the safety of the medicine today. Importantly, Sanofi acquired the OTC rights to Zantac less than three years before these lawsuits commenced, and after the medicine had been on the market for more than 35 years. In addition to Sanofi, three other companies that marketed Rx and/or branded OTC Zantac over time -- GSK, Pfizer, and Boehringer Ingelheim -- are also named as defendants in these actions. Other additionally named defendants have included dozens of generic manufacturers, retailers, and pharmaceutical distributors. The first trial that may involve Sanofi as a defendant is currently scheduled for February 2023 as a part of the California state court proceedings. Sanofi is not a defendant in many of the other cases currently set for trial. Sanofi's sales of Zantac account for only a very small percentage of the product's total sales over the 35+ years that Rx and OTC Zantac was available. Potential historical brand liability was not all passed to Sanofi upon its acquisition of Zantac. Sanofi acquired the marketing rights to Zantac from Boehringer Ingelheim in 2017. Boehringer Ingelheim continued to manufacture Zantac during the period Sanofi marketed the product. As to the respective indemnification rights and obligations of Sanofi in the context of its acquisition of the product from Boehringer Ingelheim, those obligations are being disputed between the parties in the arbitration. The arbitration award is expected to be rendered around year-end 2022. Regardless of the arbitration outcome, the legal defenses in the US litigation are strong. As of August 1, 2022, Sanofi was aware of approximately 2,850 personal injury plaintiffs across both state and federal jurisdictions with filed cases naming Sanofi in addition to other defendants. When factoring in additional Zantac cases that do not involve Sanofi, Sanofi is aware of approximately 3,450 total personal injury plaintiffs across all jurisdictions. There are other potential personal injury claimants who, in lieu of filing a court case, have instead joined a registry of "unfiled" claims established by the federal MDL court. The data on these potential cases remain preliminary and unverified and subject to change. It remains unknown how many unfiled claimants who have participated in the Registry may file suit, or whether any of those claimants will name Sanofi as a defendant in any such suits. Over time, the number of unfiled claims alleging either Rx and/or OTC use and implicating a variety of defendants in these actions has exceeded 150,000 - a significant number of these claims, however, do not implicate Sanofi. The science does not support the plaintiffs' claims in this litigation. There is no reliable evidence that Zantac causes any of the alleged injuries under real-world conditions, and Sanofi remains fully confident in its defenses. Given the strength of our case and the uncertainty of future proceedings no contingencies have been established." Reference Link

ShowHide Related Items >><<
SNY Sanofi
$43.24 /

-1.965 (-4.35%)

PFE Pfizer
$48.08 /

-1.85 (-3.71%)

GSK GSK plc
$34.51 /

-3.805 (-9.93%)

SNY Sanofi
$43.24 /

-1.965 (-4.35%)

08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 UBS
Sanofi downgraded to Neutral from Buy at UBS
08/05/22 Stifel
Sanofi price target raised to EUR 119 from EUR 115 at Stifel
07/29/22 JPMorgan
Sanofi price target raised to EUR 115 from EUR 105 at JPMorgan
GSK GSK plc
$34.51 /

-3.805 (-9.93%)

08/09/22 Baird
Mersana Therapeutics price target raised to $20 from $18 at Baird
08/08/22 UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
08/05/22 Morgan Stanley
GSK plc resumed with an Equal Weight at Morgan Stanley
PFE Pfizer
$48.08 /

-1.85 (-3.71%)

08/09/22 Wells Fargo
Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
08/08/22 Oppenheimer
Global Blood Therapeutics downgraded to Perform from Outperform at Oppenheimer
SNY Sanofi
$43.24 /

-1.965 (-4.35%)

PFE Pfizer
$48.08 /

-1.85 (-3.71%)

GSK GSK plc
$34.51 /

-3.805 (-9.93%)

SNY Sanofi
$43.24 /

-1.965 (-4.35%)

PFE Pfizer
$48.08 /

-1.85 (-3.71%)

GSK GSK plc
$34.51 /

-3.805 (-9.93%)

SNY Sanofi
$43.24 /

-1.965 (-4.35%)

PFE Pfizer
$48.08 /

-1.85 (-3.71%)

GSK GSK plc
$34.51 /

-3.805 (-9.93%)

PFE Pfizer
$48.08 /

-1.85 (-3.71%)

GSK GSK plc
$34.51 /

-3.805 (-9.93%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.